156 related articles for article (PubMed ID: 31163982)
1. Aspirin for Primary Prevention of Cardiovascular Disease.
Kheiri B; Barbarawi M; Bachuwa G; Shapiro MD
Circ Cardiovasc Qual Outcomes; 2019 Jun; 12(6):e005846. PubMed ID: 31163982
[No Abstract] [Full Text] [Related]
2. AAA- a further step towards a moratorium for aspirin in the primary prevention.
Minar E
Vasa; 2010 May; 39(2):119-122. PubMed ID: 20521434
[No Abstract] [Full Text] [Related]
3. What have we learned about using aspirin for primary prevention from the ASCEND and ARRIVE trials?
Tousoulis D
Cardiovasc Res; 2019 Feb; 115(2):e15-e16. PubMed ID: 30668678
[No Abstract] [Full Text] [Related]
4. Aspirin Efficacy in Primary Prevention: A Meta-analysis of Randomized Controlled Trials.
Barbarawi M; Kheiri B; Zayed Y; Gakhal I; Al-Abdouh A; Barbarawi O; Rashdan L; Rizk F; Bachuwa G; Alkotob ML
High Blood Press Cardiovasc Prev; 2019 Aug; 26(4):283-291. PubMed ID: 31280451
[TBL] [Abstract][Full Text] [Related]
5. Impact of acetylsalicylic acid on primary prevention of cardiovascular diseases: A meta-analysis of randomized trials.
Upadhaya S; Madala S; Baniya R; Saginala K; Khan J
Eur J Prev Cardiol; 2019 May; 26(7):746-749. PubMed ID: 30861689
[TBL] [Abstract][Full Text] [Related]
6. Aspirin effect on the incidence of major adverse cardiovascular events in patients with diabetes mellitus: a systematic review and meta-analysis.
Butalia S; Leung AA; Ghali WA; Rabi DM
Cardiovasc Diabetol; 2011 Apr; 10():25. PubMed ID: 21453547
[TBL] [Abstract][Full Text] [Related]
7. Aspirin for Primary and Secondary Prevention of Cardiovascular Disease.
Godley RW; Hernandez-Vila E
Tex Heart Inst J; 2016 Aug; 43(4):318-9. PubMed ID: 27547141
[No Abstract] [Full Text] [Related]
8. Aspirin in primary prevention: USPSTF recommendations.
Aalbers J
Cardiovasc J Afr; 2010; 21(3):176. PubMed ID: 20532445
[No Abstract] [Full Text] [Related]
9. Review of guidelines on primary prevention of cardiovascular disease with aspirin: how much evidence is needed to turn a tanker?
Matthys F; De Backer T; De Backer G; Stichele RV
Eur J Prev Cardiol; 2014 Mar; 21(3):354-65. PubMed ID: 23610452
[TBL] [Abstract][Full Text] [Related]
10. Aspirin for Primary Prevention of Cardiovascular Disease and Renal Disease Progression in Chronic Kidney Disease Patients: a Multicenter Randomized Clinical Trial (AASER Study).
Goicoechea M; de Vinuesa SG; Quiroga B; Verde E; Bernis C; Morales E; Fernández-Juárez G; de Sequera P; Verdalles U; Delgado R; Torres A; Arroyo D; Abad S; Ortiz A; Luño J
Cardiovasc Drugs Ther; 2018 Jun; 32(3):255-263. PubMed ID: 29943364
[TBL] [Abstract][Full Text] [Related]
11. Aspirin and the Primary Prevention of Cardiovascular Diseases: An Approach Based on Individualized, Integrated Estimation of Risk.
Volpe M; Battistoni A; Gallo G; Coluccia R; De Caterina R
High Blood Press Cardiovasc Prev; 2017 Sep; 24(3):331-339. PubMed ID: 28573479
[TBL] [Abstract][Full Text] [Related]
12. The ASPRE pre-eclampsia trial: implications for basic research and clinical practice.
Thilaganathan B
Cardiovasc Res; 2018 Jul; 114(8):e60-e61. PubMed ID: 30052896
[No Abstract] [Full Text] [Related]
13. Aspirin in primary prevention of cardiovascular disease in the elderly.
Galli M; Andreotti F; D'Amario D; Vergallo R; Montone RA; Porto I; Crea F
Eur Heart J Cardiovasc Pharmacother; 2020 Sep; 6(5):326-327. PubMed ID: 31504373
[No Abstract] [Full Text] [Related]
14. Aspirin for the primary prevention of cardiovascular events in patients with peripheral artery disease or diabetes mellitus. Analyses from the JPAD, POPADAD and AAA trials.
Soejima H; Morimoto T; Saito Y; Ogawa H
Thromb Haemost; 2010 Dec; 104(6):1085-8. PubMed ID: 20941462
[No Abstract] [Full Text] [Related]
15. Aspirin for primary cardiovascular disease prevention: time to re-evaluate guidelines?
Barmanray R; Hamblin PS
Intern Med J; 2019 Jan; 49(1):133-134. PubMed ID: 30680892
[No Abstract] [Full Text] [Related]
16. Aspirin for primary prevention of cardiovascular disease in women.
Jneid H
Methodist Debakey Cardiovasc J; 2010 Nov-2011 Jan; 6(4):37-42. PubMed ID: 21088658
[TBL] [Abstract][Full Text] [Related]
17. Are the current recommendations for the use of aspirin in primary prevention of cardiovascular disease applicable in low-income countries?
Noubiap JJ; Nansseu JR
Vasc Health Risk Manag; 2015; 11():503-6. PubMed ID: 26345154
[TBL] [Abstract][Full Text] [Related]
18. Aspirin for primary prevention of cardiovascular disease: is it time to move on?
Knickelbine T; Miedema MD
Curr Opin Cardiol; 2019 Sep; 34(5):510-513. PubMed ID: 31219876
[TBL] [Abstract][Full Text] [Related]
19. Aspirin for Primary Prevention of Cardiovascular Disease in Diabetes: a Review of the Evidence.
Al-Sofiani ME; Derenbecker R; Quartuccio M; Kalyani RR
Curr Diab Rep; 2019 Sep; 19(10):107. PubMed ID: 31544224
[TBL] [Abstract][Full Text] [Related]
20. [Italian intersocietary consensus document on aspirin therapy in primary cardiovascular prevention].
Volpe M; Abrignani MG; Borghi C; Coccheri S; Gresele P; Patti G; Trimarco B; De Caterina R
G Ital Cardiol (Rome); 2014; 15(7-8):442-51. PubMed ID: 25174598
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]